Report #2890626

Overview

Sex

Male

Age

Age unknown

State

NY

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

The patient took third dose of Vivotif the next day after the second dose; Case reference number US-BN-2024-002766 is a spontaneous case initially received from a physician via Med Communication (reference number: USBAV24-2971) on 11-Nov-2024 and concerns 27-year-old male patient. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient received the first dose of Vivotif vaccine (batch number: unknown), at unknown dose, orally, for indication typhoid immunization. On an unspecified date, as reported, one day off from the first dose, the patient took the second dose of Vivotif vaccine (batch number: unknown) at unknown dose, orally. On an unspecified date, as reported one day after the second dose, the patient took the third dose of Vivotif vaccine (batch number: unknown) at unknown dose, orally (explicitly coded as 'Inappropriate schedule of product administration'). On an unspecified date, reported as a day off from the third dose, the patient took the fourth dose of Vivotif vaccine (batch number: unknown) at unknown dose, orally. At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20241111-7c9870 to US-BAVARIAN NORDIC A/S-US-BN-2024-002766, in accordance with ICH guidance on WWID formatting.

Medical history

Comments: NONE